Allows Medical marijuana?: Yes
Allows Adult-Use marijuana?: No
2018 Medical Sales : $39,000,000
2022 Projected Medical Sales : $101,000,000
2018 Adult Use Sales : N/A
2022 Projected Adult Use Sales : N/A
Noteworthy Information: The Office of Medical Cannabis accepts petitions annually, June 1 - July 31, to add a new qualifying condition and/or delivery method to the MN Medical Cannabis program.
Is there a Regulatory Structure? (State Agency): Yes (Minnesota Department of Health--Division of Health Policy--Office of Medical Cannabis)
# of Dispensaries Allowed (# issued): 2 "Medical Cannabis Manufacturers" allowed. (2 have been selected.) Both must have four distribution locations, resulting in a total of 8 locations across the state. [Minnesota Medical Solutions operates in Minneapolis, Rochester, Moorhead, and Bloomington. LeafLine Labs operates in Eagan, St. Cloud, Hibbing, and St. Paul.]
# of Cultivations Allowed (# issued): Encompassed by "Medical Cannabis Manufacturers"
# of Manufacturers Allowed (# issued): Encompassed by "Medical Cannabis Manufacturers"
# of Testing labs Allowed (# issued): At least 2 allowed. Each Medical Cannabis Manufacturer contracts with at least 1 lab for testing.
Geographic Distribution of Licenses: "The distribution facilities shall be located based on geographical need throughout the state to improve patient access."
$6,000.00 non-refundable (for all license types)
Regulatory Assessment - The annual regulatory assessment is a nonrefundable, state-level fee which offsets LARA’s annual
operational costs. The regulatory assessment must be submitted before a license can be issued. The requirements in this subdivision do not apply after June 30, 2018.
Please see http://www.michigan.gov/lara/0,4601,7-154-78089_83746-453480--,00.html
Under MCL § 333.27402(2)(g), if the applicant is an individual, the individual must have been a resident of Michigan for not less than a continuous 2-year period immediately preceding the date of filing the application.
Vertical Integration Allowed, Required or Prohibited:
Medical Marijuana Qualifying Patient Conditions:
1) Cancer associated with severe/chronic pain, nausea or severe vomiting, or cachexia or severe wasting.
4) Tourette Syndrome.
5) Amyotrophic Lateral Sclerosis (ALS).
6) Seizures, including those characteristic of Epilepsy.
7) Severe and persistent muscle spasms, including those characteristic of Multiple Sclerosis.
8) Inflammatory bowel disease, including Crohn’s disease.
9) Terminal illness, with a probable life expectancy of less than one year.*
* To qualify for the program, you must suffer from cancer or a terminal illness with a probable life expectancy of under one year, if your illness or its treatment produces one or more of the following: severe or chronic pain; nausea or severe vomiting; or Cachexia or severe wasting.
10) Intractable pain
11) Post-Traumatic Stress Disorder
Conditionally effective - patients can enroll July 1, 2018 and pick up medication August 1, 2018:
* Obstructive Sleep Apnea
Yes. Random quarterly tests for pesticides.
New Leaf Cannabis Consulting can help you achieve cannabis licensure in Minnesota
The team at New Leaf Cannabis Consulting has assisted cannabis businesses launch successfully throughout the United States. Team New Leaf are high level professionals who are also veterans of this industry: We know what it takes to take you step by step through the licensing process even when regulatory details are unclear.
To learn more or get started, contact us today. We look forward to helping your cannabis business take off in Minnesota.
NEW LEAF CANNABIS BUSINESS NEWS
State By State Licensing Information
Legality of Cannabis in the United States
Leary v. United States (1969)
Ravin v. State (1975)
Conant v. McCaffrey (2000)
Gonzales v. Raich (2005)
Moncrieffe v. Holder (2013)